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Background: Upper extremity surgery is commonly performed in the ambulatory setting and is associated with moderate to
severe postoperative pain.
Methods: Patients scheduled for upper extremity orthopedic surgery with a peripheral nerve block were randomized to receive
either an ultrasound-guided single-injection supraclavicular block or ultrasound-guided median, ulnar, and radial nerve blocks
(forearm blocks) performed at the level of the mid to proximal forearm with liposomal bupivacaine (Exparel) combined with a
short-acting supraclavicular block. A sham block was performed in an attempt to blind enrollees in the control group. We
administered the EuroQol 5D-5L questionnaire preoperatively and on postoperative days 1-3 and considered the results the
primary outcome of our investigation. Block procedure times, postanesthesia care unit (PACU) length of stay, instances of
nausea/vomiting, need for narcotic administration, and patient satisfaction were also assessed.
Results: We observed no significant differences in postoperative EuroQol scores between the 2 groups and no significant
differences in patient demographics, PACU length of stay, or side effects in the PACU. In some instances, the short-acting
supraclavicular block resolved in the PACU, and these patients reported higher pain scores and required titration of analgesics
prior to discharge.
Conclusion: Larger prospective studies are needed to determine the safety and efficacy of liposomal bupivacaine in patients
undergoing upper extremity surgery. Liposomal bupivacaine is currently only approved for local anesthetic infiltration use.
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INTRODUCTION
Upper extremity orthopedic surgery is associated with
moderate to severe postoperative pain.1,2 Because these
surgeries are commonly performed as outpatient proce-
dures, attempts to optimize analgesia and minimize opioid-
related side effects are the cornerstones of postoperative
patient management. Ultrasound-guided regional anesthe-
sia techniques are safe and effective approaches to avoid a
general anesthetic as well as opioid-related side effects
while providing excellent postoperative analgesia.3
However, these techniques also have limitations. Single-
injection brachial plexus blocks—even with current long-
acting local anesthetics—are associated with a relatively
short duration of analgesia (<18 hours).3 Although contin-
uous perineural brachial plexus catheters may be placed to
prolong analgesia, instances of migration, leaking, dis-
lodgement, infection, and inappropriate quantity of drug
delivery have been reported with indwelling catheters.4 Both
long-acting brachial plexus single-injection and continuous
catheter techniques may result in prolonged numbness or
motor weakness, resulting in patient and provider dissatis-
faction and injury risk to the insensate extremity.5,6
Injection of local anesthetic around the ulnar, median, and
radial nerves at the level of the forearm (forearm blocks) is a
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safe and effective technique to achieve anesthesia or
analgesia of the hand.5-8 This approach to perineural
blockade has been associated with a lower incidence of
upper extremity weakness compared to proximal brachial
plexus blocks.5-7 The ideal regional anesthetic technique
provides dense intraoperative anesthesia, postoperative
analgesia, and minimization of motor block.6 Dufeu et al
combined a short-acting brachial plexus block with single-
injection forearm blocks using a long-lasting local anesthet-
ic in a series of patients undergoing hand surgery.6 In their
case series, the blocks were limited in duration (<12 hours),
and a substantial portion of patients reported suboptimal
pain control.
Liposomal bupivacaine (Exparel) is an encapsulated
formulation of bupivacaine designed for slow, continuous
release and prolonged analgesia.9,10 Because, at the time of
this writing, it is only approved by the US Food and Drug
Administration for wound infiltration, its use via another
route is considered off-label and should be reserved for
investigational use.9,10 We hypothesized that a forearm
block performed with liposomal bupivacaine in patients
undergoing orthopedic surgery would result in prolonged
analgesia with minimization of motor block.
METHODS
The study protocol was reviewed and approved by the
Ochsner Institutional Review Board, and written informed
consent was obtained from all subjects. The trial was
registered on clinicaltrials.gov (identifier NCT02058303)
prior to patient enrollment.
Our goal was to compare the postoperative analgesia and
health outcomes (as measured by the EuroQol 5D-5L
questionnaire [used with permission of the EuroQol Group])
in patients receiving a single-injection brachial plexus
supraclavicular block or a short-acting supraclavicular block
plus perineural injections of liposomal bupivacaine around
the median, ulnar, and radial nerves at the level of the
forearm in patients undergoing hand and wrist surgery. We
administered the EuroQol 5D-5L questionnaire preopera-
tively and on postoperative days 1-3 and considered the
results the primary outcome of our investigation.
Patients scheduled for upper extremity orthopedic sur-
gery were invited to participate in the study. Exclusion
criteria included refusal, known or suspected local anes-
thetic allergy, preexisting neurologic deficits of the upper
extremity, or daily use of opioids for >2 weeks prior to the
surgical procedure. A member of the research pharmacy
team randomized the patients by listing the designated
group in opaque envelopes that were opened immediately
prior to block placement.
The EuroQol 5D-5L was administered prior to block
performance and then daily for 3 days postoperatively. The
EuroQol 5D-5L is a validated and standardized question-
naire used to describe overall health status and is
applicable to a wide range of patient populations.11,12 The
EuroQol evaluates 5 dimensions of daily life: mobility
(walking about), self-care (washing or dressing), usual
activities (work, study, housework, family, or leisure activ-
ities), pain/discomfort, and anxiety/depression. The poten-
tial responses to these inquiries are ‘‘no problems,’’ ‘‘slight
problems,’’ ‘‘moderate problems,’’ ‘‘severe problems,’’ and
‘‘unable’’ (inability to perform the desired activity) for the
mobility, self-care, and usual activities dimensions; similar
choices are available for the pain/discomfort and anxiety/
depression dimensions. Furthermore, the EuroQol includes
a self-reported global health analog score ranging from 0
(very poor health) to 100 (excellent health).
All blocks were performed in a designated block area
prior to the surgery by staff anesthesiologists with expertise
in ultrasound-guided regional anesthesia or fellows under
their direct supervision. Block procedure time was defined
as the duration of time from the initial placement of the
ultrasound probe to the conclusion of the perineural
injection(s). A blinded research assistant assessed sensory
blockade in the various nerve distributions of the arm via
pinprick at 5-, 10-, 20-, and 30-min intervals after the block
procedure. A score of 2 was recorded if the patient had full
sensation to pinprick, while 1 and 0 indicated decreased
and absent sensation, respectively.
Control Group Procedure
Patients randomized to the control group received an
ultrasound-guided supraclavicular block. After administra-
tion of intravenous sedation and skin cleansing with
chlorhexidine gluconate/alcohol (ChloraPrep), an S-Nerve
Ultrasound System (SonoSite) L253 13-6 MHz probe was
placed in the supraclavicular region, and a 22-gauge, 5-cm
Stimuplex needle (B. Braun Medical, Inc.) was used to
deposit 30 mL of 0.5% bupivacaine incrementally around
targeted neural structures using an in-plane technique.
To further blind patients and the research assistant, a
sham block was performed in this group. After skin
cleansing and sham ultrasound imaging of the ipsilateral
forearm, 3 mL of 0.9% saline was injected subcutaneously.
Sham block procedure times were not included in the
statistical analyses.
Liposomal Bupivacaine Group Procedure
Patients randomized to the liposomal bupivacaine group
received perineural injections of 1.3% liposomal bupiva-
caine around the median, ulnar, and radial nerves at the
level of the forearm and similarly received an ultrasound-
guided supraclavicular block, but a short-acting local
anesthetic (mepivacaine) was used.
After administration of intravenous sedation and skin
preparation with chlorhexidine gluconate/alcohol, an S-
Nerve Ultrasound System L253 13-6 MHz probe was used
to identify the median, radial, and ulnar nerves in the
proximal forearm. Once the nerves were identified, a 22-
gauge, 5-cm Stimuplex needle was inserted using an in-
plane technique, and 5 mL of 1.3% liposomal bupivacaine
was injected around each respective nerve for a total of 15
mL.
After the forearm blocks were completed, the supracla-
vicular region was cleansed with chlorhexidine gluconate/
alcohol, and an S-Nerve Ultrasound System L253 13-6 MHz
probe was used to inject 30 mL of 1.5% mepivacaine around
the targeted neural structures using a 22-gauge, 5-cm
Stimuplex needle.
Intraoperative and Postoperative Care
Once transported to the operating room, patients were
administered a propofol infusion for comfort and procedural
sedation. Opioids, multimodal analgesic agents, or other
Sobero´n, JR
Volume 16, Number 4, Winter 2016 437
anesthetics were not administered intraoperatively, so an
inadequate block would not be masked. Instances of local
anesthetic supplementation by the surgical team or con-
version to general anesthesia were recorded. To minimize
surgical blood loss, a padded upper extremity tourniquet
was applied to the proximal arm and inflated to 250 mmHg
in all of the control group patients and in all but one of the
liposomal bupivacaine block group patients.
In the postanesthesia care unit (PACU), all patients were
asked to rate their pain using a numerical rating scale (NRS)
from 0-10, with 0 indicating no pain and 10 indicating the
worst pain imaginable. The length of PACU stay and
postoperative side effects were recorded.
Subjects were contacted via telephone daily for 3 days
postoperatively to administer the EuroQol questionnaire
and again 1 week after surgery to inquire about patient
satisfaction (extremely satisfied, satisfied, neutral, dissatis-
fied, or very dissatisfied) as well as weakness, numbness, or
tingling (symptoms suggestive of neurologic injury) in the
blocked extremity.
Statistical Analysis
Categorical variables are presented as counts and
percentages, with differences between the groups assessed
using chi-square or Fisher exact tests. Continuous variables
with skewed distributions were assessed using the Wilcox-
on rank-sum test. We considered P values <0.05 statistically
significant.
RESULTS
A total of 38 patients were enrolled in the study. Twenty-
one patients in the control group and 16 patients in the
liposomal bupivacaine group were included in the statistical
analysis, and the results are shown in Tables 1-3. A 17th
patient who was randomized to the liposomal bupivacaine
group developed compartment syndrome postoperatively
and was excluded from the analysis; this rare condition
(unrelated to the study intervention) and the subsequent
management are discussed elsewhere in the literature.13 No
significant differences were identified in age, sex, and body
mass index (Table 1).
We considered the results of the EuroQol 5D-5L instru-
ment the primary outcome of this investigation and report
them in Table 2, using the percentage of patient responses
for each item of the EuroQol questionnaire. No differences
in the EuroQol visual analog scale scores, mobility, self-
care, pain/discomfort, or anxiety/depression were identified
at baseline or on postoperative days 1-3. Only 2 items
reached statistical significance: a higher percentage of
patients in the control group reported moderate problems
with and inability to perform usual activities at baseline (both
P¼0.01) compared to patients in the liposomal bupivacaine
group, but this difference was not statistically significant on
postoperative days 1-3.
Because 2 block procedures were performed, the mean
block procedure time was longer in the liposomal bupiva-
caine group relative to the control group (11.8 min vs 7.0
min, respectively [P<0.0001]). We found no statistically
significant differences between the groups in length of
PACU stay, tourniquet or operative times, or patient
satisfaction.
NRS scores in the PACU were similar upon arrival,
although 3 patients in the liposomal bupivacaine group
reported pain 1 hour after PACU arrival compared to no
patients in the control group (P¼0.04). Three patients in the
liposomal bupivacaine group received narcotic analgesics
in the PACU compared to none in the control group; this
finding, however, was not statistically significant. Block
onset was slightly faster in the liposomal bupivacaine group
(Figure). No patient required conversion to general anes-
thesia, local anesthetic supplementation, or narcotic admin-
istration intraoperatively. We found no differences in
postoperative nausea or vomiting between the 2 groups.
Secondary outcomes and a list of surgical procedures are
presented in Tables 3 and 4, respectively.
No surgical or anesthetic complications were identified,
and all patients denied evidence of neurologic injury during
telephone follow-up 1 week postprocedure.
DISCUSSION
We detected no clinically significant differences in Euro-
Qol results between patients who received a single-injection
brachial plexus block and patients who received a brachial
plexus block plus perineural injections of liposomal bupiv-
acaine around the median, ulnar, and radial nerves in a
population undergoing upper extremity orthopedic surgery.
Table 1. Patient Characteristics
Variable
Control Group
(n¼21)
Liposomal Bupivacaine
Group (n¼16) P Value
Mean age, years 62.4 62.5 NS
Sex, percentage of female patients 81.8 75 NS
Mean BMI, kg/m2 28.3 27.1 NS
Mean block procedure time, min 7.0 11.8 <0.0001
Mean surgical time, min 90.6 87.8 NS
Mean tourniquet time, min 77 83.2 NS
Patients feeling ‘‘extremely satisfied’’ with anesthetic care, n (%)a 16 (80) 13 (81.3) NS
Patients feeling ‘‘satisfied’’ with anesthetic care, n (%) 3 (15) 1 (6.3) NS
Patients feeling ‘‘neutral’’ or ‘‘dissatisfied’’ with anesthetic care, n (%) 1 (5) 2 (12.5) NS
BMI, body mass index; NS, not significant.
aPatient satisfaction data were missing for one patient in the control group.
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This investigation has several limitations. While the Euro-
Qol has been validated across a wide variety of patient
populations,11,12 patients may report similar scores for
varying reasons. For example, a patient with a liposomal
bupivacaine block may report an inability to perform usual
activities because of numbness in the fingers or adherence to
the surgeon’s postoperative recommendations to keep the
hand elevated and in a sling, while another patient may
report an identical score because of poorly controlled pain or
opioid-related side effects, such as sedation or nausea. We
Table 2. EuroQol 5D-5L Resultsa
No
Problems
Slight
Problems
Moderate
Problems
Severe
Problems Unable
Treatment Control Treatment Control Treatment Control Treatment Control Treatment Control
Mobility (walking around)
Baseline 93.8 59.1 6.2 22.7 0 13.6 0 4.6 0 0
24 hours postoperatively 86.7 55.6 13.3 22.2 0 11.1 0 11.1 0 0
48 hours postoperatively 93.8 64.7 6.2 17.7 0 11.8 0 5.8 0 0
72 hours postoperatively 93.3 61.1 6.7 16.7 0 16.7 0 5.5 0 0
Self-Care (washing or dressing)
Baseline 62.5 50.0 12.5 18.2 18.8 22.7 6.2 0 0 9.1
24 hours postoperatively 13.3 11.1 40.0 11.1 26.7 27.8 6.7 16.7 13.3 33.3
48 hours postoperatively 25.0 17.7 37.5 23.5 37.5 35.3 0 11.8 0 11.7
72 hours postoperatively 20.0 5.6 46.7 50.0 33.3 27.8 0 11.1 0 5.5
Usual Activities (work, study,
housework, family, or
leisure activities)
Baseline 43.8 45.5 25.0 9.1 18.8 27.3 6.2 0 6.2 18.1
24 hours postoperatively 6.7 22.2 13.3 16.7 53.3 11.1 6.7 27.8 20.0 22.2
48 hours postoperatively 12.5 29.4 31.3 23.5 50.0 23.5 0 5.9 6.2 17.7
72 hours postoperatively 13.3 16.7 60.0 38.9 26.7 27.8 0 5.6 0 11.0
No
Pain
Slight
Pain
Moderate
Pain
Severe
Pain
Extreme
Pain
Pain/Discomfort
Baseline 18.8 13.6 31.3 22.7 43.8 45.5 6.1 9.1 0 9.1
24 hours postoperatively 13.4 5.6 33.3 27.8 26.7 27.8 13.3 16.7 13.3 22.1
48 hours postoperatively 37.5 17.7 37.5 23.5 18.8 41.2 6.2 17.6 0 0
72 hours postoperatively 26.7 27.8 46.7 27.8 26.6 38.9 0 5.5 0 0
Not Anxious
or Depressed
Slightly
Anxious
or Depressed
Moderately
Anxious
or Depressed
Severely
Anxious
or Depressed
Extremely
Anxious
or Depressed
Anxiety/Depresssion
Baseline 62.5 45.5 31.3 50.0 6.2 0 0 4.5 0 0
24 hours postoperatively 73.3 83.3 13.3 11.1 6.7 5.6 0 0 6.7 0
48 hours postoperatively 87.5 88.2 0 11.8 6.3 0 6.2 0 0 0
72 hours postoperatively 93.3 77.8 6.7 11.1 0 11.1 0 0 0 0
EuroQol Visual Analog Scale, 1-100
Baseline 75.3 72.5
24 hours postoperatively 65.7 70.6
48 hours postoperatively 73.8 75.6
72 hours postoperatively 75.3 72.4
aWith the exception of the visual analog scale (VAS) scores, all values are reported as percentages. The Euroqol VAS scores (not to be confused with pain
VAS scores) are mean nonpercentage and unitless scores used to describe overall health and well-being. A self-reported score of 0 suggests poor health,
while a score of 100 suggests excellent health.
Patients in the treatment group received perineural injections of 1.3% liposomal bupivacaine around the median, ulnar, and radial nerves at the level of the
forearm, as well as a short-acting supraclavicular block. Patients in the control group received a single-injection brachial plexus supraclavicular block.
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found no differences between the control and liposomal
bupivacaine groups in EuroQol scores in any category
during the postoperative period. Because the EuroQol
questionnaire provides only descriptive values regarding
health status, it cannot be used to determine whether an
intervention caused the measured outcomes. Furthermore,
some questions may not be entirely applicable to this study
population (for example, mobility—depending on weight-
bearing status—may be more relevant to someone under-
going lower extremity surgery). A similar study using a larger
sample size, different instrument, or a different surgical
population may yield different results and should be the
subject of future inquiry. Nonetheless, the ease of adminis-
tration and patient comprehension made the EuroQol a
desirable measurement tool.
Forearm blocks may not provide adequate coverage for
all upper extremity surgeries because they have variable
coverage of the thumb and do not provide adequate
coverage of the wrist and forearm.6,7 Although the median,
ulnar, and radial nerves were blocked with liposomal
Table 3. Secondary Outcome Measures
Variable
Control Group
(n¼21)
Liposomal Bupivacaine
Group (n¼16) P Value
Mean duration of postanesthesia care unit stay, min 95.9 80.9 NS
Conversion to general anesthesia or local anesthetic
supplementation by the surgical team, n (%) 0 (0) 0 (0) NS
NRS score >0 upon arrival, n (%) 0 (0) 0 (0) NS
NRS score >0 1 hour postprocedure, n (%)a 0 (0) 3 (30) 0.04
Need for opioid administration in PACU, n (%) 0 (0) 3 (18.8) NS
Nausea or vomiting in PACU, n (%) 0 (0) 2 (12.5) NS
NRS, numerical rating scale; NS, not significant; PACU, postanesthesia care unit.
aThree patients in the control group and 6 patients in the liposomal bupivacaine group were discharged prior to the 1-hour assessment.
Figure. Progression of sensory block. The graphs represent the (A) median nerve, (B) radial nerve, (C) ulnar nerve, and (D)
musculocutaneous nerve of the forearm. Data are presented as the percentages of patients with an absence of sensation in
the respective nerve at the specified times after the block procedure.
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bupivacaine, the musculocutaneous nerve and medial
antebrachial cutaneous nerves were not blocked. Therefore,
patients who have surgery in these areas are likely to report
pain after resolution of the surgical (mepivacaine) block,
even with functional forearm blocks. In a recently completed
prospective study, we confirmed that forearm blocks appear
to best provide anesthetic and analgesic coverage for hand
and non-thumb finger surgery.14 Because of the lack of
coverage in the aforementioned nerve distributions, a
supraclavicular block is recommended in addition to the
median, ulnar, and radial nerve blocks to avoid patient
discomfort or a need for conversion to general anesthesia in
patients undergoing surgery in the thumb, wrist, or forearm
or when prolonged upper arm tourniquet times are
anticipated. As can be inferred from Table 4, most of the
procedures in both groups involved areas outside of the
median, radial, and ulnar nerve distributions. The incom-
plete coverage of the forearm blocks, coupled with the
subjective and variable nature of reporting pain severity,
likely accounted for the absence of differences in pain
scores on the EuroQol. Despite these inherent limitations,
these blocks were chosen because of their motor-sparing
properties and benign side effect profiles.5-7
Our sample size may have been inadequate to identify
minor differences in patient outcomes or rare adverse events.
Despite the absence of adverse events in our investigation,
the results may not be generalizable to other brachial plexus
blocks. We do not know if the addition of a musculocutane-
ous nerve block in addition to the radial, ulnar, and median
nerve blocks would result in improved postoperative anal-
gesia or EuroQol scores. An alternative approach would have
been to conduct a 3-arm trial using short-acting (mepiva-
caine) supraclavicular blocks in all groups and comparing
0.5% bupivacaine, liposomal bupivacaine, and a sham
injection for radial, ulnar, and median nerve blocks for
postoperative analgesia. Further research is warranted to
determine the safety of forearm and proximal brachial plexus
block approaches using liposomal bupivacaine.
Sunderland et al15 found that patients who received a
single-injection brachial plexus block for wrist fracture
surgery were 3 times more likely to have unplanned use
of healthcare resources (such as urgent clinic or emergency
room visits) compared to patients who underwent general
anesthesia without a nerve block 48 hours postoperatively.
Furthermore, 41% of these patients reported their pain to be
‘‘excruciating,’’ ‘‘severe,’’ or ‘‘extreme’’ during this time
period. The explanation for these findings is multifactorial
but may be related to relative underdosing of opioids and
other analgesics, resolution of the block during evening
hours resulting in unanticipated pain at home, and patient
expectations.15 A theoretical benefit of the liposomal
bupivacaine forearm injections is that the primary (mepiv-
acaine) block may resolve in the PACU, allowing providers
to titrate opioids and other analgesic agents (if needed) in a
monitored medical setting to manage postoperative pain.
Further research, particularly large-scale studies, are need-
ed to determine if perineural injections of liposomal
bupivacaine result in improved use of healthcare resources.
Table 4. List of Surgical Proceduresa
Surgical Procedure(s)
Control Group
(n¼21)
Liposomal Bupivacaine
Group (n¼16)
Open reduction and internal fixation of wrist fracture 1
Open reduction and internal fixation of distal radius fracture 10 3
Open reduction and internal fixation of distal radius and ulna fracture 1
Right proximal row carpectomy with GRAFTJACKETb placement 3 2
Basal joint arthroplasty 1
Removal of metacarpophalangeal implant; revision metacarpophalangeal
arthroplasty 1
Right thumb carpometacarpal arthroplasty and carpal tunnel release 1
Right wrist distal radius removal of hardware; volar surgical scar revision 1
Distal radioulnar joint reconstruction 1
Large wrist mass excision 1
Right radial head arthroplasty 1
Left index and long finger proximal interphalangeal joint fusion 1
Left thumb basal joint arthroplasty with trapeziectomy and endoscopic
carpal tunnel release 1
Finger proximal interphalangeal joint arthroplasty 1
Thumb carpometacarpal arthroplasty 4
Finger amputation 1
Thumb collateral ligament and volar plate repair 1
Thumb arthroscopy with debridement and synovectomy 1
aNumbers reflect the number of patients in each group undergoing the respective procedure.
bWright Medical Technology, Inc.
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CONCLUSION
We were unable to detect any differences in self-reported
EuroQol scores in a small group of patients undergoing
painful upper extremity surgery with a single-injection
brachial plexus block or short-acting single-injection bra-
chial plexus block with perineural injections of liposomal
bupivacaine around the median, ulnar, and radial nerves at
the level of the forearm. Liposomal bupivacaine is only
approved for surgical wound infiltration at this time.
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